Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease

Neuroscience

Volumn 220, Issue , 2012, Pages 191-200

  Zhang, X ^a   Wang, J ^a,a   Xing, Y ^b   Gong, L ^a   Li, H ^c   Wu, Z ^a   Li, Y ^a   Wang, Y ^a   Dong, L ^a   Li, S ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c De Zhou College ^*  (China)

Author keywords

Alzheimer's disease; Apoptosis; Ginsenoside Rg1; Learning; Memory; Ovariectomy

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CASPASE; ESTRADIOL; GALACTOSE; GINSENOSIDE RG 1;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HIPPOCAMPUS; HORMONE INHIBITION; LEARNING DISORDER; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; TREATMENT DURATION; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GINSENOSIDES; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; NEUROPROTECTIVE AGENTS; OVARIECTOMY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864773402     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.06.027     Document Type: Article

References (67)

1. Aguirre C., Jayaraman A., Pike C., Baudry M. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. J Neurochem 2010, 115:1277-1287.
2. Awasthi A., Matsunaga Y., Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol 2005, 196:282-289.
3. Baum L.W. Sex, hormones, and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005, 60:736-743.
4. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002, 3:433-442.
5. Bi B.T., Lin H.B., Cheng Y.F., Zhou H., Lin T., Zhang M.Z., Li T.J., Xu J.P. Promotion of beta-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease. Neurochem Int 2012, 60:257-266.
6. Chen W.F., Lau W.S., Cheung P.Y., Guo D.A., Wong M.S. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1. Br J Pharmacol 2006, 147:542-551.
7. Chiarini A., Dal Pra I., Whitfield J.F., Armato U. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines. Ital J Anat Embryol 2006, 111:221-246.
8. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., Di Luca M. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 2002, 8:67-74.
9. Costa R.O., Ferreiro E., Cardoso S.M., Oliveira C.R., Pereira C.M. ER stress-mediated apoptotic pathway induced by Abeta peptide requires the presence of functional mitochondria. J Alzheimers Dis 2010, 20:625-636.
10. Cui X., Wang L., Zuo P., Han Z., Fang Z., Li W., Liu J. (d-galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology 2004, 5:317-325.
11. Cui X., Zuo P., Zhang Q., Li X., Hu Y., Long J., Packer L., Liu J. Chronic systemic d-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice. Protective effects of R-alpha-lipoic acid. J Neurosci Res 2006, 84:647-654.
12. Cui Y., Shu X.O., Gao Y.T., Cai H., Tao M.H., Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 2006, 163:645-653.
13. Dewachter I., Van Leuven F. Secretases as targets for the treatment of Alzheimer's disease: the prospects. Lancet Neurol 2002, 1:409-416.
14. Durairajan S.S., Yuan Q., Xie L., Chan W.S., Kum W.F., Koo I., Liu C., Song Y., Huang J.D., Klein W.L., Li M. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem Int 2008, 52(4-5):741-750.
15. Epis R., Marcello E., Gardoni F., Vastagh C., Malinverno M., Balducci C., Colombo A., Borroni B., Vara H., Dell'Agli M., Cattabeni F., Giustetto M., Borsello T., Forloni G., Padovani A., Di Luca M. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain 2010, 133:3323-3335.
16. Escribano L., Simon A.M., Gimeno E., Cuadrado-Tejedor M., Lopez de Maturana R., Garcia-Osta A., Ricobaraza A., Perez-Mediavilla A., Del Rio J., Frechilla D. Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice. Mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 2010, 35:1593-1604.
17. Fahrenholz F. The close link between retinoid signalling and the alpha-secretase ADAM10 and its potential for treating Alzheimer's disease (Commentary on Jarvis et al.). Eur J Neurosci 2010, 32:1245.
18. Fernandez-Busquets X., Ponce J., Bravo R., Arimon M., Martianez T., Gella A., Cladera J., Durany N. Modulation of amyloid beta peptide(1-42) cytotoxicity and aggregation in vitro by glucose and chondroitin sulfate. Curr Alzheimer Res 2010, 7(5):428-438.
19. Folin M., Baiguera S., Fioravanzo L., Conconi M.T., Grandi C., Nussdorfer G.G., Parnigotto P.P. Caspase-8 activation and oxidative stress are involved in the cytotoxic effect of beta-amyloid on rat brain microvascular endothelial cells. Int J Mol Med 2006, 17:431-435.
20. Fukuzaki E., Takuma K., Himeno Y., Yoshida S., Funatsu Y., Kitahara Y., Mizoguchi H., Ibi D., Koike K., Inoue M., Yamada K. Enhanced activity of hippocampal BACE1 in a mouse model of postmenopausal memory deficits. Neurosci Lett 2008, 433:141-145.
21. Gao Q.G., Chen W.F., Xie J.X., Wong M.S. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 2009, 109:1338-1347.
22. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998, 55:809-815.
23. Grady D., Gebretsadik T., Kerlikowske K., Ernster V., Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995, 85:304-313.
24. Habauzit D., Flouriot G., Pakdel F., Saligaut C. Effects of estrogens and endocrine-disrupting chemicals on cell differentiation-survival-proliferation in brain: contributions of neuronal cell lines. J Toxicol Environ Health B Crit Rev 2011, 14:300-327.
25. Hammond C.B. Women's concerns with hormone replacement therapy-compliance issues. Fertil Steril 1994, 62:157S-160S.
26. Harada H., Tamaoka A., Ishii K., Shoji S., Kametaka S., Kametani F., Saito Y., Murayama S. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci Res 2006, 54:24-29.
27. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
28. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., Roberts G.W., Masters C.L., Dotti C.G., Unsicker K., Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med 1997, 3:1016-1020.
29. Henderson V.W. (Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol 2008, 51:618-626.
30. Ho S.C., Liu J.H., Wu R.Y. Establishment of the mimetic aging effect in mice caused by d-galactose. Biogerontology 2003, 4:15-18.
31. Hooper N.M., Turner A.J. The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer's disease. Curr Med Chem 2002, 9:1107-1119.
32. Hua X., Lei M., Ding J., Han Q., Hu G., Xiao M. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes. Exp Neurol 2008, 210:709-718.
33. Hua X., Lei M., Zhang Y., Ding J., Han Q., Hu G., Xiao M. Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. Life Sci 2007, 80:1897-1905.
34. Hung Y.H., Bush A.I., Cherny R.A. Copper in the brain and Alzheimer's disease. J Biol Inorg Chem 2010, 15:61-76.
35. Jaffe A.B., Toran-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994, 269:13065-13068.
36. Kahn M.S., Kranjac D., Alonzo C.A., Haase J.H., Cedillos R.O., McLinden K.A., Boehm G.W., Chumley M.J. Prolonged elevation in hippocampal Abeta and cognitive deficits following repeated endotoxin exposure in the mouse. Behav Brain Res 2012, 229:176-184.
37. Lau W.S., Chan R.Y., Guo D.A., Wong M.S. Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol 2008, 108:64-71.
38. Lau W.S., Chen W.F., Chan R.Y., Guo D.A., Wong M.S. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells. Br J Pharmacol 2009, 156:1136-1146.
39. Lei H., Wang B., Li W.P., Yang Y., Zhou A.W., Chen M.Z. Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmacol Sin 2003, 24:230-234.
40. Li H., Li S.L., Wu Z.H., Gong L., Wang J.L., Li Y.Z. Effect of traditional Chinese herbal Bu-Wang-San on synaptic plasticity in ovariectomised rats. J Pharm Pharmacol 2009, 61:95-101.
41. Liu J., Chang L., Roselli F., Almeida O.F., Gao X., Wang X., Yew D.T., Wu Y. Amyloid-beta induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J Alzheimers Dis 2010, 22:541-556.
42. Liu Q., Kou J.P., Yu B.Y. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-kappaB activation. Neurochem Int 2011, 58:119-125.
43. Liu X., Xu K., Yan M., Wang Y., Zheng X. Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. Neurochem Int 2010, 57:588-599.
44. Logan S.M., Sarkar S.N., Zhang Z., Simpkins J.W. Estrogen-induced signaling attenuates soluble Abeta peptide-mediated dysfunction of pathways in synaptic plasticity. Brain Res 2011, 1383:1-12.
45. Lu X.Z., Wang J.H., Wu X., Zhou L., Wang L., Zhang X.W., Cao K.J., Huang J. Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway. Acta Pharmacol Sin 2008, 29:1209-1214.
46. Marin R. (Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease. Front Physiol 2011, 2:23.
47. Meng Y., Wang R., Yang F., Ji Z.J., Fang L., Sheng S.L. Amyloid precursor protein 17-mer peptide ameliorates hippocampal neurodegeneration in ovariectomized rats. Neurosci Lett 2010, 468:173-177.
48. Misiti F., Clementi M.E., Giardina B. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function. Neurochem Int 2010, 56(4):597-602.
49. Musicco M. Gender differences in the occurrence of Alzheimer's disease. Funct Neurol 2009, 24:89-92.
50. Nord L.C., Sundqvist J., Andersson E., Fried G. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells. Neurodegener Dis 2010, 7:349-364.
51. Park Y.H., Son I.H., Kim B., Lyu Y.S., Moon H.I., Kang H.W. Poria cocos water extract (PCW) protects PC12 neuronal cells from beta-amyloid-induced cell death through antioxidant and antiapoptotic functions. Pharmazie 2009, 64(11):760-764.
52. Potter H., Dressler D. The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol 2000, 18:125-126.
53. Rosario E.R., Chang L., Head E.H., Stanczyk F.Z., Pike C.J. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 2011, 32:604-613.
54. Ryan J., Scali J., Carriere I., Ritchie K., Ancelin M.L. Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int Psychogeriatr 2008, 20:47-56.
55. Selkoe D.J. (Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996, 271:18295-18298.
56. Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011, 1:a006189.
57. Shi Y.Q., Huang T.W., Chen L.M., Pan X.D., Zhang J., Zhu Y.G., Chen X.C. Ginsenoside Rg1 attenuates amyloid-beta ontent, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice. J Alzheimers Dis 2009, 1:1-2.
58. Storey E., Cappai R. The amyloid precursor protein of Alzheimer's disease and the Abeta peptide. Neuropathol Appl Neurobiol 1999, 25(2):81-97.
59. Strom J.O., Theodorsson A., Theodorsson E. Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia. Int J Mol Sci 2011, 12:1533-1562.
60. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
61. Tian J., Ishibashi K., Reiser K., Grebe R., Biswal S., Gehlbach P., Handa J.T. Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci USA 2005, 102:11846-11851.
62. Tong Y., Xu Y., Scearce-Levie K., Ptacek L.J., Fu Y.H. COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenetics 2010, 11:41-52.
63. Wang D., Huang Y., Li Q., Xu S., Liu X. Anti-apoptotic effect of ginsenoside Rg1 on neuron after neonatal hypoxia ischemia brain damage. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010, 24:1107-1112.
64. Wang W.X., Wang W., Chen K.J. Protective effect and mechanism of ginsenosides on central nerve system of animals. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005, 25:89-93.
65. Wang Y.H., Du G.H. Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells. J Asian Nat Prod Res 2009, 11:604-612.
66. Wei H., Li L., Song Q., Ai H., Chu J., Li W. Behavioural study of the d-galactose induced aging model in C57BL/6J mice. Behav Brain Res 2005, 157:245-251.
67. Zhao E., Mu Q. Phytoestrogen biological actions on mammalian reproductive system and cancer growth. Sci Pharm 2011, 79:1-20.